Founders Fund

Founders Fund is a San Francisco-based venture capital firm that backs science and technology companies across multiple stages, from seed to late-stage. It pursues transformative technologies and follows a founder-friendly investment approach that provides substantial support with minimal interference. The firm invests in ventures solving difficult problems across sectors such as aerospace and transportation, artificial intelligence, advanced computing, energy, healthcare, biotechnology, cybersecurity, fintech, consumer internet, software, robotics, and related technology fields. It has backed notable companies early, including SpaceX, Palantir, and Facebook, reflecting a history of partnering with ambitious founders to scale breakthrough technologies.

Jennifer Campbell

Partner

Lauren Gross

Partner and COO

Bridget Harris

Associate

Joey Krug

Partner

Sean Liu

Partner

Past deals in Health Diagnostics

Ataraxis

Series A in 2025
Ataraxis is an AI-based diagnostic platform that helps develop personalized treatment plans.

Nucleus

Series A in 2025
Nucleus operates a biotechnology research platform focused on next-generation consumer genetic testing and analysis. The company allows users to upload their genetic information obtained from established providers and employs proprietary algorithms to calculate polygenic risk scores and assess disease risk based on genetic variants. Utilizing whole-genome sequencing, Nucleus delivers comprehensive genetic analysis, facilitating advancements in human health and medicine. The results are presented on a user-friendly platform, making complex genetic information accessible and understandable for users.

Even

Series A in 2024
Even partners with top hospitals nationwide to offer unlimited diagnostics, consultations, and hospitalization coverage worth INR 50 lakhs via a single monthly subscription.

Q Bio

Venture Round in 2024
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

9amHealth

Series A in 2024
9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

Forward

Series E in 2023
Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

Even

Convertible Note in 2022
Even partners with top hospitals nationwide to offer unlimited diagnostics, consultations, and hospitalization coverage worth INR 50 lakhs via a single monthly subscription.

Modern Animal

Series C in 2022
Modern Animal is a veterinary platform and clinic operator based in Los Angeles that combines in-clinic care with at-home services and a mobile app. The company provides general and preventive veterinary care, including wellness visits, vaccinations, parasite prevention, routine labs, dental care, and surgeries such as spays and mass removals, along with diagnostics like ultrasound and radiology, and nutritional and behavioral assessments. Through its platform, clients can access unlimited exams, 24/7 virtual care, in-app prescription requests and delivery, and flexible options such as walk-in and drop-off visits. The business supports a membership model designed to deepen relationships among doctors, pets and owners while leveraging technology and design to improve access, convenience and the overall pet-care experience.

Nucleus

Seed Round in 2022
Nucleus operates a biotechnology research platform focused on next-generation consumer genetic testing and analysis. The company allows users to upload their genetic information obtained from established providers and employs proprietary algorithms to calculate polygenic risk scores and assess disease risk based on genetic variants. Utilizing whole-genome sequencing, Nucleus delivers comprehensive genetic analysis, facilitating advancements in human health and medicine. The results are presented on a user-friendly platform, making complex genetic information accessible and understandable for users.

Ultima Genomics

Venture Round in 2022
Ultima Genomics is a biotechnology company established in 2016 and headquartered in Newark, California. It specializes in genome-scale sequencing technology, focusing on providing analytical services to various enterprises. By employing an open substrate, Ultima Genomics creates a vast, low-cost reaction surface that facilitates billions of reads without relying on expensive flow cells or complex fluidic systems. The company utilizes specialized sequencing hardware combined with machine learning techniques to ensure reproducible and accurate results. This innovative approach enables clients to obtain genomic reports at scale, enhancing the speed and efficiency of sequencing while significantly reducing costs. Ultima Genomics aims to harness the potential of genomic information to drive advancements in biology and improve human health.

9amHealth

Series A in 2022
9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

Cor

Series A in 2022
COR helps you implement globally-proven healthy lifestyle practices, then shows you a totally new type of data about how your body responds. Optimize your lifestyle and discover the impact of different daily customs with precise, science-based self-knowledge.

Alinea Health

Venture Round in 2022
Alinea Health is a health-tech startup that provides solutions for corporate health. It utilizes large amounts of data and proprietary algorithms to assist the client company's beneficiaries in navigating their health plans, providing personalized and unbiased guidance, recommendations from the most effective doctors in the accredited network, and conveniences such as scheduling consultations and exams. In addition to continuous monitoring, its doctors use the Lifestyle Medicine methodology to promote a healthy lifestyle and lower the risk of developing chronic diseases.

Garner Health

Series B in 2021
Garner Health is a technology company established in 2019 and based in New York, NY, that focuses on enhancing the healthcare experience for employees through employer partnerships. By leveraging a doctor quality analytics platform, Garner Health provides insights into clinical quality and total care costs, helping employers direct their employees to high-quality healthcare providers. The platform also offers an overlay account that covers employee deductibles and coinsurance, allowing employees to reduce out-of-pocket expenses while ensuring employers achieve guaranteed savings. Through this approach, Garner Health aims to improve healthcare quality and affordability for both employees and their employers.

Elemy

Series B in 2021
Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in autism care since its launch in April 2020. The company has expanded its services to address a range of developmental and mental health issues, including ADHD, OCD, depression, and social anxiety. Elemy employs a technology-driven care model that modernizes traditional systems by offering in-home and online Applied Behavior Analysis (ABA) services. This approach enhances accessibility and clinical outcomes while reducing costs. The platform features free autism assessments and matches children with therapists to create individualized treatment plans tailored to their specific needs. Elemy's multidisciplinary clinical team oversees an integrated care model, demonstrating significant improvements in behavior for many children.

Teiko.bio

Venture Round in 2021
Founded in 2020, Teiko.bio is a Salt Lake City-based company that provides an immune profiling platform. This platform supports global clinical trials by offering blood preservation kits, cytometry panels, data reports, and tailored gating services. It enables clinicians to make informed decisions regarding patient response.

9amHealth

Seed Round in 2021
9amHealth is a healthcare service provider that aims to deliver comprehensive medical support for chronic conditions such as diabetes, hypertension, and hyperlipidemia. The company offers personalized care plans, prescription medication, at-home lab tests, and unlimited virtual visits, ensuring that patients have direct access to affordable and compassionate care. By redesigning all care elements into a single digital service, 9amHealth caters to the modern realities of patients' lives, making healthcare always available and convenient, even for those without insurance. Its focus on chronic conditions highlights its commitment to improving the health and well-being of customers in the United States.

HeartLab

Seed Round in 2021
HeartLab develops an AI-powered cardiology imaging platform that integrates the end-to-end imaging workflow. The company builds diagnostic tools that analyze echocardiograms and other cardiac imaging to help doctors diagnose and treat cardiovascular disease. Its tools automate repetitive measurements, enabling faster interpretation and improved efficiency for clinicians, with the goal of advancing cardiology care globally.

Calibrate

Series B in 2021
Calibrate Health, Inc., established in 2020 and based in New York, specializes in digital metabolic health services for sustainable weight loss. The company combines FDA-approved metabolic medications with a comprehensive curriculum and personalized virtual coaching to address the root causes of weight issues and promote long-term behavior change. Calibrate's approach, led by experts in obesity and nutrition science, aims to improve metabolic health and drive lasting results.

Modern Animal

Series A in 2021
Modern Animal is a veterinary platform and clinic operator based in Los Angeles that combines in-clinic care with at-home services and a mobile app. The company provides general and preventive veterinary care, including wellness visits, vaccinations, parasite prevention, routine labs, dental care, and surgeries such as spays and mass removals, along with diagnostics like ultrasound and radiology, and nutritional and behavioral assessments. Through its platform, clients can access unlimited exams, 24/7 virtual care, in-app prescription requests and delivery, and flexible options such as walk-in and drop-off visits. The business supports a membership model designed to deepen relationships among doctors, pets and owners while leveraging technology and design to improve access, convenience and the overall pet-care experience.

Modern Animal

Series B in 2021
Modern Animal is a veterinary platform and clinic operator based in Los Angeles that combines in-clinic care with at-home services and a mobile app. The company provides general and preventive veterinary care, including wellness visits, vaccinations, parasite prevention, routine labs, dental care, and surgeries such as spays and mass removals, along with diagnostics like ultrasound and radiology, and nutritional and behavioral assessments. Through its platform, clients can access unlimited exams, 24/7 virtual care, in-app prescription requests and delivery, and flexible options such as walk-in and drop-off visits. The business supports a membership model designed to deepen relationships among doctors, pets and owners while leveraging technology and design to improve access, convenience and the overall pet-care experience.

Even

Seed Round in 2021
Even partners with top hospitals nationwide to offer unlimited diagnostics, consultations, and hospitalization coverage worth INR 50 lakhs via a single monthly subscription.

Maximus

Seed Round in 2021
Maximus is a consumer telemedicine company for men’s health and hormone optimization. Maximus is revolutionizing the performance enhancement space by democratizing doctor-prescribed protocols developed by some of the world’s leading experts in men’s health. Maximus’ King Protocol utilizes a convenient prescription medication capsule to stimulate natural testosterone production, proven by at-home lab tests. Maximus was established in 2020 by Cameron Sepah in Santa Monica, California.

Clearing

Seed Round in 2021
Clearing is a digital healthcare platform built to serve the more than 50M chronic pain sufferers in the United States. In partnership with leading physicians and researchers at Harvard, Johns Hopkins, and the Hospital for Special Surgery, and with significant funding from top-tier investors Bessemer Venture Partners, Founders Fund, Breyer Capital, and a host of leading healthcare and consumer entrepreneurs (including the founders of Hims, Seamless Grubhub, Flatiron Health, Forward Health, Curology and more) we are on a mission to provide patients with access to comprehensive, opioid-free pain relief.

Collective Health

Series F in 2021
Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

Elemy

Series A in 2021
Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in autism care since its launch in April 2020. The company has expanded its services to address a range of developmental and mental health issues, including ADHD, OCD, depression, and social anxiety. Elemy employs a technology-driven care model that modernizes traditional systems by offering in-home and online Applied Behavior Analysis (ABA) services. This approach enhances accessibility and clinical outcomes while reducing costs. The platform features free autism assessments and matches children with therapists to create individualized treatment plans tailored to their specific needs. Elemy's multidisciplinary clinical team oversees an integrated care model, demonstrating significant improvements in behavior for many children.

Forward

Series D in 2021
Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

Garner Health

Series A in 2021
Garner Health is a technology company established in 2019 and based in New York, NY, that focuses on enhancing the healthcare experience for employees through employer partnerships. By leveraging a doctor quality analytics platform, Garner Health provides insights into clinical quality and total care costs, helping employers direct their employees to high-quality healthcare providers. The platform also offers an overlay account that covers employee deductibles and coinsurance, allowing employees to reduce out-of-pocket expenses while ensuring employers achieve guaranteed savings. Through this approach, Garner Health aims to improve healthcare quality and affordability for both employees and their employers.

HeartLab

Seed Round in 2020
HeartLab develops an AI-powered cardiology imaging platform that integrates the end-to-end imaging workflow. The company builds diagnostic tools that analyze echocardiograms and other cardiac imaging to help doctors diagnose and treat cardiovascular disease. Its tools automate repetitive measurements, enabling faster interpretation and improved efficiency for clinicians, with the goal of advancing cardiology care globally.

Tempo

Series B in 2020
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.

Siren Care

Series B in 2020
Siren Care develops wearable health technology for diabetic foot health monitoring. The company offers Siren diabetic socks and a foot temperature monitoring system that continuously tracks foot temperature to detect early signs of inflammation and diabetic foot ulcers, helping prevent complications such as amputations. Data from the socks can be accessed via a mobile application and shared with providers, including podiatrists, to support monitoring and timely intervention. It serves patients and healthcare providers through its flagship Siren Diabetic Foot Program. Founded in 2015 and based in San Francisco, Siren Care focuses on proactive foot health management for individuals at risk of diabetic foot complications.

Q Bio

Series B in 2020
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Scanwell Health

Seed Round in 2019
Scanwell Health, Inc. is a healthcare company that specializes in at-home diagnostic solutions, focusing on urine testing kits. Founded in 2018 and headquartered in Los Angeles, California, Scanwell Health has developed an FDA-cleared urine testing application that allows users to obtain clinical-grade results via their smartphones. The company's flagship product is a urinary tract infection test kit that not only provides accurate testing results but also connects users with online medical professionals for same-day treatment and prescriptions. By combining innovative technology with accessible healthcare services, Scanwell Health aims to enhance proactive health management for individuals seeking convenient and affordable medical care.

Modern Animal

Seed Round in 2019
Modern Animal is a veterinary platform and clinic operator based in Los Angeles that combines in-clinic care with at-home services and a mobile app. The company provides general and preventive veterinary care, including wellness visits, vaccinations, parasite prevention, routine labs, dental care, and surgeries such as spays and mass removals, along with diagnostics like ultrasound and radiology, and nutritional and behavioral assessments. Through its platform, clients can access unlimited exams, 24/7 virtual care, in-app prescription requests and delivery, and flexible options such as walk-in and drop-off visits. The business supports a membership model designed to deepen relationships among doctors, pets and owners while leveraging technology and design to improve access, convenience and the overall pet-care experience.

Tempo

Series A in 2019
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.

Collective Health

Series E in 2019
Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

Untitled Labs

Seed Round in 2019
Untitled Labs, Inc. is a consumer application idea lab based in San Francisco, California, founded in 2018. The company focuses on testing and developing innovative business ideas in various sectors, including social and professional networking, mobility, personal finance, premium services, health and wellness, travel, photography, and dating. Led by serial entrepreneur Roger Dickey, Untitled Labs aims to create valuable technology products that resonate with large audiences. By systematically evaluating multiple concepts, the company seeks to identify and build a sustainable business around the most promising idea.

Siren Care

Series A in 2018
Siren Care develops wearable health technology for diabetic foot health monitoring. The company offers Siren diabetic socks and a foot temperature monitoring system that continuously tracks foot temperature to detect early signs of inflammation and diabetic foot ulcers, helping prevent complications such as amputations. Data from the socks can be accessed via a mobile application and shared with providers, including podiatrists, to support monitoring and timely intervention. It serves patients and healthcare providers through its flagship Siren Diabetic Foot Program. Founded in 2015 and based in San Francisco, Siren Care focuses on proactive foot health management for individuals at risk of diabetic foot complications.

Vium

Series B in 2018
Vium, Inc. is a biotechnology company founded in 2013 and headquartered in San Mateo, California. It specializes in developing digital biomarkers aimed at enhancing preclinical research and animal welfare. The company is fully accredited by AAALAC International and has received significant commendation for its commitment to the principles of humane animal research. Vium's digital platform, known as Digital Vivarium and Vium Cloud, utilizes advanced technologies such as computer vision, artificial intelligence, and machine learning to non-invasively collect physiological metrics and behaviors. This innovative approach enables researchers and drug developers to gain improved insights into disease progression, thereby facilitating better decision-making regarding which compounds should progress to clinical trials. Its clientele includes a diverse array of biotechnology, pharmaceutical, and academic institutions, as well as novel therapeutic laboratories, all seeking more sensitive and accurate data for replicable studies.

CTRL-Labs

Series B in 2018
CTRL-Labs develops neural interface technologies that enable humans to interact with machines using natural movements and thoughts. Their flagship product, CTRL-kit, is a wireless, non-invasive electromyography device that translates neural signals into control for applications in XR, robotics, productivity, and clinical research.

Virta Health

Series B in 2018
Virta Health is a San Francisco–based health technology company that specializes in treating type 2 diabetes through an online, physician-supported program. The company combines nutritional biochemistry, data science, and digital tools to deliver on-demand care via a continuous remote care platform, providing physicians and health coaches who guide patients to reduce blood sugar and lose weight without medications or surgery. Founded in 2014, Virta offers a treatment approach aimed at reversing type 2 diabetes and improving related metabolic and cardiovascular health.

Siren Care

Seed Round in 2018
Siren Care develops wearable health technology for diabetic foot health monitoring. The company offers Siren diabetic socks and a foot temperature monitoring system that continuously tracks foot temperature to detect early signs of inflammation and diabetic foot ulcers, helping prevent complications such as amputations. Data from the socks can be accessed via a mobile application and shared with providers, including podiatrists, to support monitoring and timely intervention. It serves patients and healthcare providers through its flagship Siren Diabetic Foot Program. Founded in 2015 and based in San Francisco, Siren Care focuses on proactive foot health management for individuals at risk of diabetic foot complications.

Neurotrack

Series B in 2018
Neurotrack is a digital health company focused on the early detection and management of Alzheimer's disease and other dementias. It offers turnkey cognitive assessment platforms for providers to facilitate rapid, patient-guided screening and ongoing monitoring of cognitive function, usable in clinic or at home to fit diverse workflows. The platform employs eye-tracking technology and culturally-agnostic symbols to deliver rapid assessments with instant, objective scoring integrated with electronic health records, and supports remote and in-clinic administration, ongoing monitoring tools, and educational resources addressing modifiable risk factors. Neurotrack has published peer-reviewed research, holds patents on its proprietary technology, and has FDA Class II medical device status. Founded in 2012 and based in Redwood City, California.

Collective Health

Series D in 2018
Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

Counsyl

Venture Round in 2017
Counsyl is a health technology company specializing in DNA screening services for individuals and families. The company focuses on providing critical information that can significantly influence health outcomes, enabling proactive measures and informed decision-making. With a strong commitment to accessibility, Counsyl has screened over 500,000 patients and collaborated with more than 6,000 healthcare professionals through its accredited clinical laboratory. It employs sophisticated technology and custom robotic automation to analyze blood and saliva samples with precision and efficiency. The platform not only aids in family planning through its Family Prep Screen but also encompasses informed pregnancy and cancer screening. Recognized for its innovative approach, Counsyl has received accolades such as the Wall Street Journal’s Innovation Award for Medicine and has been listed among Scientific American's "Top 10 World Changing Ideas." The company combines the expertise of scientists, engineers, and clinical professionals to enhance communication between patients and healthcare providers regarding medical results.

Neurotrack

Series A in 2016
Neurotrack is a digital health company focused on the early detection and management of Alzheimer's disease and other dementias. It offers turnkey cognitive assessment platforms for providers to facilitate rapid, patient-guided screening and ongoing monitoring of cognitive function, usable in clinic or at home to fit diverse workflows. The platform employs eye-tracking technology and culturally-agnostic symbols to deliver rapid assessments with instant, objective scoring integrated with electronic health records, and supports remote and in-clinic administration, ongoing monitoring tools, and educational resources addressing modifiable risk factors. Neurotrack has published peer-reviewed research, holds patents on its proprietary technology, and has FDA Class II medical device status. Founded in 2012 and based in Redwood City, California.

Q Bio

Seed Round in 2016
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Collective Health

Series C in 2015
Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

Genesis Healthcare

Venture Round in 2015
Genesis Healthcare Co. is a privately-owned genetic testing and research company founded in 2004 and headquartered in Tokyo, Japan, with additional offices in Singapore and Taiwan. The company is recognized as a market leader in consumer genetics in Japan, offering its services under the brand "GeneLife." Genesis Healthcare possesses the largest genetic database in Japan and Asia, encompassing over 988,000 individuals and more than 1,500 diseases. The company utilizes advanced technologies such as PCR, Microarray, and NGS for research and clinically validated genetic testing services. In addition to its commercial offerings, Genesis Healthcare collaborates with government agencies to establish genetic testing guidelines, ensuring accuracy and the protection of individuals' genetic information. By promoting preventive healthcare through genetic testing, Genesis Healthcare aims to enhance public health outcomes across Southeast Asia.

Tribogenics

Series B in 2015
Tribogenics is a technology development company based in Los Angeles, California, focused on creating low-cost, portable X-ray solutions for various industries, including mining, industrial, military, and medical imaging. Utilizing triboluminescence technology originally developed at UCLA, the company has designed miniature X-ray devices that leverage a process akin to static electricity to generate X-rays. This innovative approach allows for convenient and accessible X-ray functions, enabling customers to conduct materials analysis and imaging in diverse settings without the constraints of traditional, larger X-ray systems.

Vium

Series A in 2015
Vium, Inc. is a biotechnology company founded in 2013 and headquartered in San Mateo, California. It specializes in developing digital biomarkers aimed at enhancing preclinical research and animal welfare. The company is fully accredited by AAALAC International and has received significant commendation for its commitment to the principles of humane animal research. Vium's digital platform, known as Digital Vivarium and Vium Cloud, utilizes advanced technologies such as computer vision, artificial intelligence, and machine learning to non-invasively collect physiological metrics and behaviors. This innovative approach enables researchers and drug developers to gain improved insights into disease progression, thereby facilitating better decision-making regarding which compounds should progress to clinical trials. Its clientele includes a diverse array of biotechnology, pharmaceutical, and academic institutions, as well as novel therapeutic laboratories, all seeking more sensitive and accurate data for replicable studies.

Collective Health

Series B in 2015
Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

Collective Health

Series B in 2015
Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

Misfit Wearables

Series C in 2014
Misfit Wearables, founded in 2011 and headquartered in Burlingame, California, specializes in creating innovative wearable devices aimed at enhancing consumer health and fitness. The company focuses on developing products that encourage users to adopt active lifestyles and cultivate healthy habits. One of its flagship offerings is the Shine, a sleek personal activity tracker that effortlessly syncs with smartphones. As a pioneer in the wearable sensor technology sector, Misfit is dedicated to producing stylish and functional devices that people will want to wear consistently.

Vium

Series A in 2014
Vium, Inc. is a biotechnology company founded in 2013 and headquartered in San Mateo, California. It specializes in developing digital biomarkers aimed at enhancing preclinical research and animal welfare. The company is fully accredited by AAALAC International and has received significant commendation for its commitment to the principles of humane animal research. Vium's digital platform, known as Digital Vivarium and Vium Cloud, utilizes advanced technologies such as computer vision, artificial intelligence, and machine learning to non-invasively collect physiological metrics and behaviors. This innovative approach enables researchers and drug developers to gain improved insights into disease progression, thereby facilitating better decision-making regarding which compounds should progress to clinical trials. Its clientele includes a diverse array of biotechnology, pharmaceutical, and academic institutions, as well as novel therapeutic laboratories, all seeking more sensitive and accurate data for replicable studies.

Glow

Series B in 2014
Glow, Inc. is a company focused on women's health, particularly in the areas of fertility, pregnancy, and reproductive well-being. Founded in 2013 and based in San Francisco, it develops and operates mobile applications designed to offer information and support throughout various phases of women's reproductive health. Its primary offerings include Ruby By Glow, which provides period and ovulation tracking alongside health and sex education; Glow, an ovulation calculator; and Glow Nurture, a pregnancy tracking solution. Additionally, Glow offers a community fund program aimed at making infertility treatment more accessible through collective risk pooling among couples. This non-profit initiative also provides financial assistance to accredited infertility clinics for couples who do not achieve pregnancy. Glow's applications utilize data analysis to help users track their cycles and enhance fertility outcomes, offering resources and support for those experiencing pregnancy loss as well.

Collective Health

Series A in 2014
Collective Health provides a cloud-based health benefits platform that unifies medical, dental, vision, pharmacy, and related programs into a single administration experience, helping employers simplify benefits, guide employees in understanding and navigating care, and manage costs and outcomes. The platform offers integrated administration of all health plans through one portal, with live concierge support and digital tools to find and manage care, and connects employees with medical, pharmacy, dental, and vision providers. Headquartered in San Francisco with offices in Chicago and Lehi, it aims to reduce the administrative burden of delivering benefits while improving member experience and overall health outcomes.

Misfit Wearables

Series B in 2013
Misfit Wearables, founded in 2011 and headquartered in Burlingame, California, specializes in creating innovative wearable devices aimed at enhancing consumer health and fitness. The company focuses on developing products that encourage users to adopt active lifestyles and cultivate healthy habits. One of its flagship offerings is the Shine, a sleek personal activity tracker that effortlessly syncs with smartphones. As a pioneer in the wearable sensor technology sector, Misfit is dedicated to producing stylish and functional devices that people will want to wear consistently.

Neurotrack

Seed Round in 2013
Neurotrack is a digital health company focused on the early detection and management of Alzheimer's disease and other dementias. It offers turnkey cognitive assessment platforms for providers to facilitate rapid, patient-guided screening and ongoing monitoring of cognitive function, usable in clinic or at home to fit diverse workflows. The platform employs eye-tracking technology and culturally-agnostic symbols to deliver rapid assessments with instant, objective scoring integrated with electronic health records, and supports remote and in-clinic administration, ongoing monitoring tools, and educational resources addressing modifiable risk factors. Neurotrack has published peer-reviewed research, holds patents on its proprietary technology, and has FDA Class II medical device status. Founded in 2012 and based in Redwood City, California.

Glow

Series A in 2013
Glow, Inc. is a company focused on women's health, particularly in the areas of fertility, pregnancy, and reproductive well-being. Founded in 2013 and based in San Francisco, it develops and operates mobile applications designed to offer information and support throughout various phases of women's reproductive health. Its primary offerings include Ruby By Glow, which provides period and ovulation tracking alongside health and sex education; Glow, an ovulation calculator; and Glow Nurture, a pregnancy tracking solution. Additionally, Glow offers a community fund program aimed at making infertility treatment more accessible through collective risk pooling among couples. This non-profit initiative also provides financial assistance to accredited infertility clinics for couples who do not achieve pregnancy. Glow's applications utilize data analysis to help users track their cycles and enhance fertility outcomes, offering resources and support for those experiencing pregnancy loss as well.

Tribogenics

Series A in 2012
Tribogenics is a technology development company based in Los Angeles, California, focused on creating low-cost, portable X-ray solutions for various industries, including mining, industrial, military, and medical imaging. Utilizing triboluminescence technology originally developed at UCLA, the company has designed miniature X-ray devices that leverage a process akin to static electricity to generate X-rays. This innovative approach allows for convenient and accessible X-ray functions, enabling customers to conduct materials analysis and imaging in diverse settings without the constraints of traditional, larger X-ray systems.

Misfit Wearables

Series A in 2012
Misfit Wearables, founded in 2011 and headquartered in Burlingame, California, specializes in creating innovative wearable devices aimed at enhancing consumer health and fitness. The company focuses on developing products that encourage users to adopt active lifestyles and cultivate healthy habits. One of its flagship offerings is the Shine, a sleek personal activity tracker that effortlessly syncs with smartphones. As a pioneer in the wearable sensor technology sector, Misfit is dedicated to producing stylish and functional devices that people will want to wear consistently.

Counsyl

Private Equity Round in 2011
Counsyl is a health technology company specializing in DNA screening services for individuals and families. The company focuses on providing critical information that can significantly influence health outcomes, enabling proactive measures and informed decision-making. With a strong commitment to accessibility, Counsyl has screened over 500,000 patients and collaborated with more than 6,000 healthcare professionals through its accredited clinical laboratory. It employs sophisticated technology and custom robotic automation to analyze blood and saliva samples with precision and efficiency. The platform not only aids in family planning through its Family Prep Screen but also encompasses informed pregnancy and cancer screening. Recognized for its innovative approach, Counsyl has received accolades such as the Wall Street Journal’s Innovation Award for Medicine and has been listed among Scientific American's "Top 10 World Changing Ideas." The company combines the expertise of scientists, engineers, and clinical professionals to enhance communication between patients and healthcare providers regarding medical results.

100Plus

Seed Round in 2011
100Plus is a rapidly growing remote patient monitoring platform designed to enhance the management of chronic patients, particularly among the elderly. The company provides an integrated solution that includes patient outreach, device setup, patient engagement, and automatic billing, all without requiring smartphones, apps, Bluetooth, or WiFi. This simplifies the process for both patients and healthcare providers. By delivering fully configured medical devices at no cost to Medicare patients or practices, 100Plus facilitates continuous monitoring of high-risk seniors, enabling healthcare professionals to proactively engage with patients. This approach aims to reduce the need for expensive episodic care and improve overall quality of life for patients.

GoodRx

Seed Round in 2011
GoodRx operates a digital platform that compares prescription drug prices from local and mail-order pharmacies across the United States. It provides consumers with pricing information, pharmacy coupons, and tips to save on medication costs.

Pathway Genomics

Series A in 2009
Pathway Genomics Corporation is a clinical laboratory based in San Diego, California, that specializes in providing genetic testing services to healthcare professionals and their patients both domestically and internationally. The company offers a variety of tests, including liquid biopsy, hereditary cancer assessments, and pharmacogenomics, which evaluates how individuals respond to specific medications. Additionally, Pathway Genomics provides services related to general health and wellness, carrier screening, and corporate wellness initiatives. Their testing portfolio addresses numerous health concerns, including cancer risk, cardiac health, inherited diseases, and responses to nutrition and exercise. Pathway Genomics is recognized for its commitment to quality, holding CAP accreditation and establishing strategic partnerships with organizations like Standard Process and Rainbow Genomics. The company was incorporated in 2008, reflecting its ongoing role in advancing personalized medicine.

HeartLab

HeartLab develops an AI-powered cardiology imaging platform that integrates the end-to-end imaging workflow. The company builds diagnostic tools that analyze echocardiograms and other cardiac imaging to help doctors diagnose and treat cardiovascular disease. Its tools automate repetitive measurements, enabling faster interpretation and improved efficiency for clinicians, with the goal of advancing cardiology care globally.

HeartLab

HeartLab develops an AI-powered cardiology imaging platform that integrates the end-to-end imaging workflow. The company builds diagnostic tools that analyze echocardiograms and other cardiac imaging to help doctors diagnose and treat cardiovascular disease. Its tools automate repetitive measurements, enabling faster interpretation and improved efficiency for clinicians, with the goal of advancing cardiology care globally.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.